Autres langues Xtacy Therapeutics Corp.

Actions

XTCY

CA98423G1072

Temps Différé Canadian Securities Exchange Autres places de cotation 21:12:40 06/05/2024			Varia. 5j.	Varia. 1 janv.
0,025 ^CAD	-44,44 %		-37,50 %	-44,44 %

17/04	Xtacy Therapeutics Corp. annonce ses résultats pour le premier trimestre clos le 31 décembre 2023	CI
15/04	Xtacy Therapeutics Corp. annonce ses résultats pour l'exercice clos le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Xtacy Therapeutics Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	17/04
Xtacy Therapeutics Corp. Reports Earnings Results for the Full Year Ended September 30, 2023	15/04
Xtacy Therapeutics Corp. Expands MDMA Platform Pharmaceutical Grade Psychedelic Solutions to Solve Unmet Medical Needs	06/12
XTACY Therapeutics Announces Debt Settlement	05/10/23
Global Wellness Strategies Inc. will Change its Name to XTACY Therapeutics Corp	25/09/23
Global Wellness Strategies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23/08/23
Global Wellness Strategies : Voting Instruction Form (“VIF”) – Annual General Meeting to be held on Wednesday, August 16, 2023	17/07/23
Global Wellness Strategies : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 16, 2023	17/07/23
Global Wellness Strategies : GWS NEWS RELEASE	18/04/23
Global Wellness Strategies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	18/04/23
Global Wellness Strategies Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	03/04/23
Global Wellness Strategies Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	29/03/23
Global Wellness Strategies Inc. Auditor Raises 'Going Concern' Doubt	29/03/23
Global Wellness Strategies : Files Annual Statements September 2022	29/03/23
Global Wellness Strategies Inc. Announces Formation of Wholly Owned Pharma Subsidiary Focused on Clinical Trials	17/11/22
Global Wellness Strategies Effervescent Cannabis Products Approved to Launch GWS Achieves Major Milestone Partnering with Hempsana Holdings	31/10/22
Global Wellness Strategies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	02/09/22
Global Wellness Strategies Inc. Signs Custom Manufacturing Agreement with Hempsana Holdings	02/08/22
Global Wellness Strategies : Information Circular	29/07/22
Global Wellness Strategies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	01/06/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Xtacy Therapeutics Corp.

Actions

XTCY

CA98423G1072

Autres langues

Filtres